Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
about
Models of chronic obstructive pulmonary diseaseThe pattern of methacholine responsiveness in mice is dependent on antigen challenge doseRisk Factors Associated with Irreversible Airway Obstruction in Asthma: A Systematic Review and Meta-AnalysisAsthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta AnalysisThe geriatric asthma: pitfalls and challengesPatterns of inflammation and the use of reversibility testing in smokers with airway complaintsSmoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA studyRepeatability of exhaled nitric oxide measurements in patients with COPDFixed airways obstruction among patients with severe asthma: findings from the Singapore General Hospital-Severe Asthma Phenotype Study.Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.Central role of cellular senescence in TSLP-induced airway remodeling in asthma.NKT cells in the induced sputum of severe asthmatics.Asthma in the Elderly: Can We Distinguish It from COPD?The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the ElderlyAn official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Asthma, airway biology, and nasal disorders in AJRCCM 2003.Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003.Relaxant effects of a hydroalcoholic extract of Ruta graveolens on isolated rat tracheal ringsChronic obstructive pulmonary disease: importance of diagnosis.Pulmonary biomarkers in chronic obstructive pulmonary disease.The challenges of chronic obstructive pulmonary diseases (COPD)--a perspective.Current concepts in mechanisms of emphysema.Aspects on pathophysiological mechanisms in COPD.Differentiating COPD from asthma in clinical practice.Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.Growing old with asthma: what are the changes and challenges?Relationship between hepatitis C virus infection and pulmonary disorders: potential mechanisms of interaction.Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis.Bronchial brushings for investigating airway inflammation and remodelling.Past, present and future uses of methacholine testing.Do small airway abnormalities characterize asthma phenotypes? In search of proof.TGF-β1 as a therapeutic target for pulmonary fibrosis and COPD.Improving early-stage diagnosis and management of COPD in primary care.Biomarker discovery in asthma and COPD by proteomic approaches.Pulmonary physiology: future directions for lung function testing in COPD.The asthma COPD overlap syndrome (ACOS).Asthma in the older adult: presentation, considerations and clinical management.Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.
P2860
Q24798450-BFABFB0F-EA2A-4178-BA7C-EAA86BCDF0AFQ24799142-9CD81524-108A-4B4E-A0CC-B1756137AE6DQ26749403-D5EF3E84-DA9E-41E4-A163-7543E33FE638Q26786069-134EDDBC-6B60-464C-9BA5-E9BC790C5008Q28079363-2FCB5882-DB02-4365-84BC-9BD84F80B29EQ33245416-B6D64A9D-9DB6-41B3-80E1-329DFEEF32FFQ34499210-3AADBE38-43B1-4C1B-8971-07CCF39070B0Q34619392-C62620CA-5917-4DFD-AEC3-75D9D9F43CB0Q34695211-EC876AE7-7769-4641-BA03-DCE9B0292566Q34997202-1FCA472C-971B-49C2-B55A-6F6B3EC6F8BEQ35027776-BCAC27E3-5141-4390-B10B-B96BAA244D49Q35070524-47B27175-9853-49E7-A86B-506D7A1040D1Q35110244-70DB4B9A-EDAD-4E1B-8CBE-B81ECE1069A5Q35494872-C7E53BE3-A3B5-4425-B1A6-E6A7D0B2DE7EQ35534747-5DC9E019-F1C2-4953-B097-C6CC043D57DEQ35626613-7AB64B09-D1C6-4583-9252-E84D4F5F73C1Q35626624-D9974AE1-0860-499C-823B-0585E70041FCQ35710988-DE6E0697-5875-4C9A-8A31-A21EF4A55237Q35851108-12E832B5-1885-48D9-9129-EAF512DE9F5BQ36429908-D68D9592-B9D5-46E3-98E6-C0E5FCF65E1CQ36669465-473C7BF0-57A0-4D9B-BC22-60F39D11EE0EQ36746478-8064B783-F85A-4F51-8D56-E9CE1DA3C45BQ36909567-6C924767-2C88-491F-B892-C450069F4326Q36951507-EA48BFAA-4DBC-4C44-8B1F-7E2F7E34C0B5Q37732234-89CD12E8-F671-4013-9583-67D7C4DCF1D7Q37734453-096408B5-A79A-4BFB-91F5-190683627FE4Q37755272-0F75A38D-4897-402C-8AF3-2CAB2EFCACFFQ37776727-0F379613-40A2-4244-A8D1-285E8014A12CQ37790365-8F0BA51A-7E00-4407-9F9E-06F8B26277F9Q37882032-391F13FF-76B5-4B42-8BED-31494E0A1E8DQ38025728-8B404A34-D515-4EB2-B887-5A48BFAC2959Q38026991-30900756-DE41-4E51-A70A-3F5E00BAAE20Q38177343-551A9F0B-A1A6-4300-8160-BC1D20C06BB2Q38241642-02CFBB6E-03E8-4530-8446-1B4550785926Q38245908-C66B9910-4014-4CD1-9864-D6D21FD6F1B8Q38254519-DB2B378B-ACF0-4911-91C8-2DC13A9CAF82Q38364870-4406F3FA-543C-4286-A957-415F97B8039AQ38584352-0A56CB36-A565-4263-A0AA-06B6AD6EB1F7Q38644007-48181B59-6E70-4D5E-9775-F79ABAD528CAQ38740312-0BA3C36E-96C5-49FF-AC9E-07AF530BDC2A
P2860
Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease
description
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 08 November 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2003
@uk
name
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@en
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@nl
type
label
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@en
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@nl
prefLabel
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@en
Differences in Airway Inflamma ...... Obstructive Pulmonary Disease
@nl
P2093
P50
P921
P1476
Differences in airway inflamma ...... obstructive pulmonary disease
@en
P2093
Adalberto Ciaccia
Guido Ligabue
Kamelija Busljetic
Lorenzo Corbetta
Micaela Romagnoli
P304
P356
10.1164/RCCM.200203-183OC
P407
P577
2002-11-08T00:00:00Z